by Marina Chenery | Apr 29, 2020 | Drug Discovery Applications, Publications and presentations
This article outlines practical applications of deep learning on drug discovery data. It introduces some of the research behind our Cerella technology. Summary When looking to apply artificial intelligence in drug discovery, one of the main challenges is around the...
by Marina Chenery | Apr 28, 2020 | Webinars
Practical Applications of Deep Learning to Imputation of Drug Discovery Data This webinar was presented by our guest Julian Levell (Constellation Pharmaceuticals) and Ben Irwin (Optibrium). We discussed limitations of pharmaceutical data impacting conventional...
by Marina Chenery | Apr 1, 2020 | News
CAMBRIDGE, UK, 01 April, 2020 – Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further...